Research and experimental development on natural sciences and engineering
FIKKAN PHARMA AS
Revenue 2025
NOK 666,000
Operating profit
NOK 509,000
Equity
NOK 2.5m
Incorporated
2015
Share capital
NOK 30,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 666k | |
| Total operating costs | 158k | |
| Operating profit (EBIT) | 509k | |
| Net financial items | 565k | |
| Profit for the year | 959k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 2.8m | |
| of which current assets | 1.6m | |
| Equity | 2.5m | |
| Total liabilities | 234k |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.